摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-5-((S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde

中文名称
——
中文别名
——
英文名称
(R)-5-((S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde
英文别名
(5R)-5-[(1S)-4,5-dimethoxy-3-oxo-1H-2-benzofuran-1-yl]-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde
(R)-5-((S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde化学式
CAS
——
化学式
C23H23NO8
mdl
——
分子量
441.438
InChiKey
VHCDTXJWDGJDHU-MSOLQXFVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    32
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    92.8
  • 氢给体数:
    0
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    新型Noscapine 1,3-二炔基衍生物作为有效的微管蛋白结合抗癌剂的合理设计,化学合成和细胞评价
    摘要:
    基于我们在计算机上的努力,结合微管蛋白并显示出对一组乳腺癌细胞的抗癌活性,我们提出了一类新型的Noscapine衍生物,一种镇咳植物生物碱的1,3-二炔基-Noscapinoids,Noscapine 。结构活性分析指出,异喹啉环的C-9位置可以通过偶联1,3-二炔基结构基序进行修饰,以进行合理设计,并筛选出一系列具有较强耐受性的新型1,3-二炔基-类芥子油苷(20–22)与微管蛋白的结合亲和力。选定的1,3-二炔基-类胡萝卜素类化合物20-22预测的结合能提高了-6.568 kcal / mol,对于20为-7.367 kcal / mol,对于21为-7.922 kcal / mol,对于22为-7.922 kcal / mol。与铅分子(-5.246 kcal / mol)相比。这些新颖的衍生物是化学合成的,并基于使用两种人乳腺腺癌MCF-7和MDAMB-231以及从患者中分离出的一
    DOI:
    10.1016/j.jmgm.2021.107933
  • 作为产物:
    参考文献:
    名称:
    新型Noscapine 1,3-二炔基衍生物作为有效的微管蛋白结合抗癌剂的合理设计,化学合成和细胞评价
    摘要:
    基于我们在计算机上的努力,结合微管蛋白并显示出对一组乳腺癌细胞的抗癌活性,我们提出了一类新型的Noscapine衍生物,一种镇咳植物生物碱的1,3-二炔基-Noscapinoids,Noscapine 。结构活性分析指出,异喹啉环的C-9位置可以通过偶联1,3-二炔基结构基序进行修饰,以进行合理设计,并筛选出一系列具有较强耐受性的新型1,3-二炔基-类芥子油苷(20–22)与微管蛋白的结合亲和力。选定的1,3-二炔基-类胡萝卜素类化合物20-22预测的结合能提高了-6.568 kcal / mol,对于20为-7.367 kcal / mol,对于21为-7.922 kcal / mol,对于22为-7.922 kcal / mol。与铅分子(-5.246 kcal / mol)相比。这些新颖的衍生物是化学合成的,并基于使用两种人乳腺腺癌MCF-7和MDAMB-231以及从患者中分离出的一
    DOI:
    10.1016/j.jmgm.2021.107933
点击查看最新优质反应信息

文献信息

  • Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
    申请人:Acuff Cory
    公开号:US20110274651A1
    公开(公告)日:2011-11-10
    Compositions and methods for treating or preventing infectious diseases, and inhibiting the ability of microbes to travel within mammalian cells, and inhibiting microbial replication, are disclosed. The compositions include various noscapine analogs, which are capable of blocking the movement of viruses and other microbes within mammalian and other cells by inhibiting the cytoplasmic transport mechanisms within the cells. The compositions described herein include an effective amount of the noscapine analogues described herein, along with a pharmaceutically acceptable carrier or excipient. The compositions can also include one or more additional antimicrobial compounds.
    本发明公开了用于治疗或预防传染病、抑制微生物在哺乳动物细胞内移动和抑制微生物复制能力的组合物和方法。该组合物包括各种诺斯卡平类似物,能够通过抑制细胞内的胞质转运机制,阻止病毒和其他微生物在哺乳动物和其他细胞内移动。本发明所描述的组合物包括所述诺斯卡平类似物的有效量,以及药学上可接受的载体或赋形剂。该组合物还可以包括一个或多个额外的抗微生物化合物。
  • <scp>9‐Ethynyl</scp> noscapine induces <scp>G2</scp> /M arrest and apoptosis by disrupting tubulin polymerization in cervical cancer
    作者:Praveen Kumar Reddy Nagireddy、Dinesh Kumar、Vamsi Krishna Kommalapati、Ravi Kumar Pedapati、Venkateswarlu Kojja、Anjana Devi Tangutur、Srinivas Kantevari
    DOI:10.1002/ddr.21888
    日期:——
    Noscapine is a phthalide isoquinoline alkaloid present in the latex of Papaver somniferum and has demonstrated potent antitumor activity in various cancer models. Structural changes in the core molecule of noscapine architecture have produced a number of potent analogs. We have recently synthesized the novel noscapine analogs (3, 4, and 5) with different functional groups appended at ninth position of
    Noscapine 是一种存在于Papaver somniferum乳胶中的苯酞异喹啉生物碱,并在各种癌症模型中显示出有效的抗肿瘤活性。诺斯卡品结构核心分子的结构变化产生了许多有效的类似物。我们最近合成了新的诺斯卡品类似物(3、4和5 ) ,在天然诺斯卡品的第 9个位置附加了不同的官能团。这些化合物的抗癌活性已经使用各种人类癌细胞系进行了研究,例如 HeLa(宫颈癌)、DU-145(前列腺癌)、MCF-7(乳腺癌)和 IMR-32(神经母细胞瘤)。该系列中的一种化合物,9-乙炔基诺斯卡平(5),已证明对 HeLa 细胞具有良好的抗癌活性。生物学研究表明,化合物5以浓度依赖性方式降低了 HeLa 细胞中的细胞活力和集落形成。为了进一步详细揭示该机制,我们评估了化合物5对细胞周期进程、微管动力学和细胞凋亡的影响。细胞周期和蛋白质印迹分析显示,9-乙炔基诺斯卡品处理导致 G2/M 细胞周期停滞并降低
  • Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer
    作者:Rajesh Kumar Meher、Pratyush Pragyandipta、Praveen Kumar Reddy、Ravikumar Pedaparti、Srinivas Kantevari、Pradeep K. Naik
    DOI:10.1080/07391102.2021.1982008
    日期:2022.12.19
  • Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents
    作者:Amiya Kumar Patel、Rajesh Kumar Meher、Praveen Kumar Reddy、Ravi Kumar Pedapati、Pratyush Pragyandipta、Srinivas Kantevari、Manas Ranjan Naik、Pradeep Kumar Naik
    DOI:10.1016/j.jmgm.2021.107933
    日期:2021.7
    breast cancer cells isolated from patients. Interestingly, all these derivatives inhibited cellular proliferation in all the cancer cells that ranged between 6.2 to 38.9 μM, which is 6.7 to 1.5 fold lower than that of noscapine. Unlike previously reported derivatives of noscapine that arrests cells in the S-phase, these novel derivatives effectively inhibit proliferation of cancer cells, arrests cell
    基于我们在计算机上的努力,结合微管蛋白并显示出对一组乳腺癌细胞的抗癌活性,我们提出了一类新型的Noscapine衍生物,一种镇咳植物生物碱的1,3-二炔基-Noscapinoids,Noscapine 。结构活性分析指出,异喹啉环的C-9位置可以通过偶联1,3-二炔基结构基序进行修饰,以进行合理设计,并筛选出一系列具有较强耐受性的新型1,3-二炔基-类芥子油苷(20–22)与微管蛋白的结合亲和力。选定的1,3-二炔基-类胡萝卜素类化合物20-22预测的结合能提高了-6.568 kcal / mol,对于20为-7.367 kcal / mol,对于21为-7.922 kcal / mol,对于22为-7.922 kcal / mol。与铅分子(-5.246 kcal / mol)相比。这些新颖的衍生物是化学合成的,并基于使用两种人乳腺腺癌MCF-7和MDAMB-231以及从患者中分离出的一
查看更多

同类化合物

阿托喹啉 那可汀 那可丁N-氧化物 诺司卡品 盐酸盐 水合物 细果角茴香碱 紫堇明 盐酸那可丁一水合物 盐酸诺格考平 盐酸白毛莨碱 曲托喹啉 山缘草定碱 咖喏定 北美黄连碱 [S-(R*,R*)]-6,7-二甲氧基-3-(5,6,7,8-四氢-4-羟基-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基)苯酞 [6S,(+)]-6-[(1S)-1,2,3,4-四氢-6,7-二甲氧基-2-甲基异喹啉-1-基]呋喃并[3,4-e]-1,3-苯并二氧戊环-8(6H)-酮 7-氨基-4,5,6-三乙氧基-3-(6,7,8-三甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基)-3H-2-苯并呋喃-1-酮 7-O-去甲基alpha-那可丁 6,7-二甲氧基-3-[(5R)-4-甲氧基-6-甲基-7,8-二氢-5H-[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-3H-2-苯并呋喃-1-酮 3-异喹啉-1-基-3H-2-苯并呋喃-1-酮 (3S)-6,7-二甲氧基-3-[(5S)-6-甲基-5,6,7,8-四氢[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-2-苯并呋喃-1(3H)-酮 (3S)-3-[(1R)-6,7-二羟基-8-甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基]-6,7-二甲氧基-3H-2-苯并呋喃-1-酮 (-)-荷苞牡丹碱甲溴化物 (-)-荷苞牡丹碱 (-)-荷包牡丹碱甲溴化物 (-)-荷包牡丹碱甲氯化物 (-)-紫堇明 (+)-荷苞牡丹碱甲氯化物 (+)-荷包牡丹碱 hydrastidine isohydrastidine 5,9-bis-(4,5-dimethoxy-3-oxo-phthalan-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline (S,R)-9-bromo noscapine (S)-3-{(R)-9-[(2-chloro-acetylamino)-methyl]-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-6,7-dimethoxy-phthalide (S)-6,7-dimethoxy-3-{(R)-4-methoxy-6-methyl-9-[(2-morpholino-acetylamino)-methyl]-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl}-phthalide (R)-5-((S)-4,5-dimethoxy-3-oxo-phthalan-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline-9-carboxylic acid methyl ester 4-(((S)-1-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)butane-1-sulfonic acid ethyl 4-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)benzoate N-(3-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)phenyl)acetamide (S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-7-hydroxy-6-methoxyisobenzofuran-1(3H)-one ethyl 2-chloro-5-((5R)-5-((1S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-9-yl)benzoate 3-(((S)-1-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-5-methoxy-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)propane-1-sulfonic acid 4-(((S)-5-methoxy-1-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3-oxo-1,3-dihydroisobenzofuran-4-yl)oxy)butane-1-sulfonic acid (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-9-(4-vinylphenyl)-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one (R)-5-((S)-4,5-dimethoxy-3-oxo-1,3-dihydroisobenzofuran-1-yl)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinoline-9-carbaldehyde N-desmethyl-N-carbethoxynarcotine (S)-3-((R)-9-bromo-4-methoxy-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxyisobenzofuran-1(3H)-one 9-Fluoro-Noscapine 9-Nitro-Noscapine 7-benzyloxy-6-methoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one 7-benzyloxy-6-methoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one